{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:10:09Z","timestamp":1768317009039,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1136\/ard.59.5.351","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:45:32Z","timestamp":1027766732000},"page":"351-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of circulating immune complexes on the binding of rheumatoid factor to histones"],"prefix":"10.1016","volume":"59","author":[{"given":"H\u00e9l\u00e8ne A Elicha","family":"Gussin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine L","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Teodorescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.59.5.351_bib1","first-page":"704","article-title":"Nucleosomes: the structural quantum in chromosomes.","volume":"66","author":"Olins","year":"1978","journal-title":"American Scientist"},{"key":"10.1136\/ard.59.5.351_bib2","series-title":"Textbook of clinical biochemistry with clinical correlation.","first-page":"637","article-title":"DNA: the replicative process and repair.","author":"Aktipis","year":"1992"},{"key":"10.1136\/ard.59.5.351_bib3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ki.1995.336","article-title":"Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus [editorial].","volume":"48","author":"Tax","year":"1995","journal-title":"Kidney Int"},{"key":"10.1136\/ard.59.5.351_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/jaut.1997.0172","article-title":"Isolation and characterization of apoptotic nucleosomes, free and complexed with lupus autoantibody generated during hybridoma B-cell apoptosis.","volume":"11","author":"Cabrespines","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.59.5.351_bib5","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1084\/jem.151.6.1514","article-title":"Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype.","volume":"151","author":"Agnello","year":"1980","journal-title":"J Exp Med"},{"key":"10.1136\/ard.59.5.351_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF01857092","article-title":"Cross-reacting rheumatoid factors and lupus erythematosus (LE)-factors.","volume":"4","author":"Hannestad","year":"1981","journal-title":"Springer Seminars in Immunopathology"},{"key":"10.1136\/ard.59.5.351_bib7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1084\/jem.159.5.1429","article-title":"Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity.","volume":"159","author":"Rubin","year":"1984","journal-title":"J Exp Med"},{"key":"10.1136\/ard.59.5.351_bib8","series-title":"Systemic lupus erythematosus.","first-page":"227","article-title":"Antihistone antibodies.","author":"Rubin","year":"1999"},{"key":"10.1136\/ard.59.5.351_bib9","first-page":"1037","article-title":"Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity and predictive value for rheumatoid arthritis.","volume":"24","author":"Swedler","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.5.351_bib10","series-title":"Current protocols in immunology.","first-page":"13.0.3","article-title":"Complement.","author":"Giclas","year":"1994"},{"key":"10.1136\/ard.59.5.351_bib11","series-title":"Statistics for biologists.","author":"Campbell","year":"1979"},{"key":"10.1136\/ard.59.5.351_bib12","doi-asserted-by":"crossref","first-page":"18414","DOI":"10.1016\/S0021-9258(17)44768-5","article-title":"An immune complex selective affinity matrix utilizing a synthetic peptide.","volume":"265","author":"Baumann","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.59.5.351_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0090-1229(86)90142-X","article-title":"Characterization of the soluble immune complexes that are detected by three different techniques.","volume":"38","author":"Van Der Giessen","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1136\/ard.59.5.351_bib14","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/anr.1780321020","article-title":"Antihistone antibodies in rheumatoid arthritis and Felty\u2019s syndrome.","volume":"32","author":"Cohen","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.5.351_bib15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/eji.1830180724","article-title":"The double reactivity of a human monoclonal rheumatoid factor to IgG and histones is related to distinct binding sites.","volume":"18","author":"Pasquali","year":"1988","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.59.5.351_bib16","first-page":"326","article-title":"Antibodies to histones in rheumatoid arthritis.","volume":"5","author":"Muzellec","year":"1988","journal-title":"Diagnostic Clinical Immunology"},{"key":"10.1136\/ard.59.5.351_bib17","first-page":"43","article-title":"Serology and immunoglobulin profile in rheumatoid arthritis.","volume":"41","author":"Adhya","year":"1998","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1136\/ard.59.5.351_bib18","first-page":"2012","article-title":"Manifestations extra-articulaires de la polyarthrite rhumatoide.","volume":"47","author":"de Bandt","year":"1997","journal-title":"La Revue du Praticien (Paris)"},{"key":"10.1136\/ard.59.5.351_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.1780210304","article-title":"Comparison of the presence of immune complexes in Felty\u2019s syndrome and rheumatoid arthritis.","volume":"21","author":"Andreis","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.5.351_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/art.1780220702","article-title":"Increased C1q binding immune complexes in Felty\u2019s syndrome: comparison with uncomplicated rheumatoid arthritis.","volume":"22","author":"Hurd","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.5.351_bib21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1172\/JCI115643","article-title":"Changes in normal glycosylation mechanisms in autoimmune rheumatic diseases.","volume":"89","author":"Axford","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.59.5.351_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2249.1994.tb07011.x","article-title":"Inhibition of histone\/anti-histone reactivity by histone-binding serum components; differential effect on anti-H1 versus anti-H2B antibodies.","volume":"95","author":"Bustos","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.59.5.351_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0090-1229(89)90207-9","article-title":"Autoantibodies to histones and their subfractions in chronic liver diseases.","volume":"51","author":"Konikoff","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1136\/ard.59.5.351_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/11.supp4.25","article-title":"Type II mixed cryoglobulinemia, hepatitis C infection, and glomerulonephritis.","volume":"II(suppl 4)","author":"Fornasieri","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/ard.59.5.351_bib25","first-page":"391","article-title":"Kryoglobulinamie und chronische Lebererkrankungen.","volume":"36","author":"Csepregi","year":"1998","journal-title":"Z Gastroenterol"},{"key":"10.1136\/ard.59.5.351_bib26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0896-8411(05)80019-8","article-title":"Cross-reactivity of monoclonal anti-DNA antibodies with heparan-sulfate is mediated via bound DNA histone complexes.","volume":"3","author":"Termaat","year":"1990","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.59.5.351_bib27","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.4049\/jimmunol.154.5.2424","article-title":"Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA\/histone\/type IV collagen complex.","volume":"154","author":"Bernstein","year":"1995","journal-title":"J Immunol"},{"key":"10.1136\/ard.59.5.351_bib28","first-page":"S364","article-title":"Results of a randomized double blind trial of the Prosorba\u00ae column for treatment of severe rheumatoid arthritis [abstract].","volume":"41(suppl 9)","author":"Felson","year":"1998","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724382226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724382226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.59.5.351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T04:52:22Z","timestamp":1737262342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724382226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0003496724382226"],"URL":"https:\/\/doi.org\/10.1136\/ard.59.5.351","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of circulating immune complexes on the binding of rheumatoid factor to histones","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.59.5.351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}